Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
HOME > Drug Approval & Reimbursement in 2025
Drug Approval & Reimbursement in 2025
-
Japan Approves Moderna RSV Vaccine, GSK’s ADC, and More
May 20, 2025
-
Chuikyo OKs Listing of Tevimbra, Camzyos, Tremfya, and More
May 15, 2025
-
Chugai’s DMD Gene Therapy Snags Conditional Approval in Japan
May 14, 2025
-
J-TEC’s JACC Widens Label into Knee Osteoarthritis
May 14, 2025
-
Japan Approves Spikevax’s Prefilled Syringe Version
April 24, 2025
-
Amgen’s Imdelltra, CSL’s Andembry to Join NHI Price List on April 16
April 10, 2025
-
Japan Approves Tablet Form of Chugai’s SMA Med Evrysdi
March 31, 2025
-
Japan Approves J&J’s Lazcluze, Genmab’s Tivdak, and More
March 28, 2025
-
Japan Approves Tablet Forms of Sleep Aid Melatobel: Nobelpharma
March 18, 2025
-
Zepbound, Qalsody, and More New Drugs Set for Japan Listing on March 19
March 13, 2025
-
Japan Approves CSL’s HAE Med Andembry, Tecentriq Sarcoma Use, and More
February 21, 2025
-
CureApp’s Alcoholism Therapy App Approved in Japan
February 19, 2025
-
Japan Approves Shionogi’s Therapy App for Pediatric ADHD
February 19, 2025
-
Espha’s Januvia Generic on Approval Roster towards June Listing
February 18, 2025
-
UCB Bags Japan Approval for Bimzelx’s 320 mg Auto-Injector
February 7, 2025
ページ
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…